By 2020, close to three-quarters of clinical trials may be performed by professional contract research organisations (CROs). Ramya Sriram at Kolabtree illustrates how CROs have already proven successful for pharmaceutical companies carrying out clinical trials, whilst also questioning if freelance scientists can add to their expertise as the clinical trial service market grows.